Adipose tissue is an important endocrine organ that secretes a number of adipokines, like Leptin (LEP). The aim this study was to investigate the prevalence of single nucleotide polymorphisms in LEP gene (LEP 3 0 UTR A/C, À2548 G/A) .6] (P = .003). The K109R polymorphism was associated with obesity (P = .025) and seems to significantly decrease the LEP levels (P < .001). Concerning LEP G2548A polymorphism, our results showed that the OR of obesity associated with 2548 AA/GG was 1.87 [1.106-2.78] P = .028 vs 1.41[1.035-1.85] P = .045 for 223AA/GG polymorphism. In our haplotype analysis, one haplotype seems to be the more protective and one other seems to be the highest risk to obesity. LEP 3 0 UTR A/C and LEPR K109R polymorphisms were associated with Leptin level and obesity.
Summary
Adipose tissue is an important endocrine organ that secretes a number of adipoki- . The K109R polymorphism was associated with obesity (P = .025) and seems to significantly decrease the LEP levels (P < .001). Concerning LEP G2548A polymorphism, our results showed that the OR of obesity associated with 2548 AA/GG was 1.87 [1.106-2.78] P = .028 vs 1.41[1.035-1.85] P = .045 for 223AA/GG polymorphism. In our haplotype analysis, one haplotype seems to be the more protective and one other seems to be the highest risk to obesity. LEP 3 0 UTR A/C and LEPR K109R polymorphisms were associated with Leptin level and obesity.
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| INTRODUCTION
Obesity is a major influential factor in the development of complex cardiovascular diseases. Many studies in humans indicate that obesity is related to interaction between genes and environmental factors. 1 Obesity is defined as an imbalance between caloric consumption and energy expenditure. Several proteins have been implicated in this energy imbalance, such as adipokines, proteins produced by adipose tissue. One of the most important adipokines is Leptin (LEP).
It was reported that the circulating LEP levels correlate with body adiposity in both adults and children 9 and the high value of LEP levels found in obese individuals are believed to indicate LEP resistance. 10 Based on conflicting results of LEP and LEPR polymorphisms association with obesity and LEP level in different populations, we aimed to study the relationship between two SNPs (single nucleotide polymorphisms) in LEP (À2548 G/A (rs7799039) and 3 0 UTR A/C (rs11761556) and two SNPs in LEPR rs1137101 (Gln223Arg) and rs1137100 (Arg109Lys) on Leptin level and obesity in Tunisian volunteers. . In both groups, we excluded subjects taking lipid-lowering drugs and all those having renal failure, thyroid disease and hepatic pathology. All the members of the study completed a structured questionnaire. Sociodemographic characteristics, family and personal history, smoking habits, and drug intake if any were collected.
| MATERIALS AND METHODS

| Study subjects
The participants underwent physical examinations and laboratory tests. The examiners undertook training in the questionnaire collections and measures. The study was approved by the Hospital Medical Ethic Committee «CHU SAH CE30/2011», and informed consent was obtained from all study subjects.
| Anthropometric parameters and blood pressure measurements
Weight and height were measured on the subjects barefooted and lightly clothed. Waist circumference (WC) was measured by trained examiner from the narrowest point between the lower borders of the rib cage and the iliac crest. BMI was calculated as body weight (kg)/height 2 (m 2 ), and obesity was defined as BMI ≥ 30 kg/m 2 . 12 Blood pressure was measured three times from the left arm of seated subjects with a blood pressure monitor after 20 minutes of rest.
| Biochemical measurements
Blood was collected for laboratory testing after a 12-hour overnight fast. All biochemical parameter studies were performed on the Synckrom CX7 Clinical System using the Beckman reagents (Beckman, Fullerton, CA). Serum total cholesterol (TC) and triglycerides (TG) were determined by enzymatic assays. High-density lipoprotein cholesterol (HDL-C) was measured by direct enzymatic assay. Low-density lipoprotein cholesterol (LDL-C) was measured by direct assay and was calculated with the Friedewald formula. 13 
| Definitions of risk factors
| DNA analysis
Genomic DNA was isolated from peripheral blood leucocytes by the salting out method. 18 Genotyping of LEP À2548 G/A (rs7799039) and 3 0 UTR A/C (rs11761556) and two SNPs in LEPR Gln223Arg (223Q/R) and Arg109Lys (109 K/R) were determined by polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) according to the conditions adapted from previous studies, 19, 20 and the digest product was resolved by 2% and 3% agarose gel electrophoresis. The products were electrophoresed on agarose gel (2% for the LEP variants or on 3% for LEPR SNPs) and visualized by ethidium bromide staining. Primers sequences and restriction enzymes used are given in Table 1 . Correlation between LEP and other biological and anthropometric parameters was studied using Spearmen test. The odds ratios (ORs), two-tailed P-values and 95% confidence interval (CI) were calculated as a measure of the association of the SNPs and haplotype with the presence of obesity and were adjusted to potential confounder parameters (P < .25) by binary logistic regression. A P-value of <.05 was considered statistically significant for all tests.
| Statistical analysis
| RESULTS
| Patient characteristics
The clinical and biological characteristics of our study are presented in Table 2 (modified from Table 2 by Boumaiza et al. 5 ) The prevalence of hypertension, diabetes, metabolic syndrome and cardiovascular disease was higher in obese group (P < .001). Compared with non-obese subjects, the obese subjects had higher weight, waist circumference, TG, TC, HOMA-IR, and insulin and Leptin levels but lower HDL-C concentration. Dyslipidaemia frequencies (P = .923), daily energy intake (P = .636) and LDL-C concentrations (P = .262) did not show significant differences between the two groups.
| Association between Leptin, Leptin receptor polymorphisms and Leptin level
Results given in | 123 (P < .001), whereas no statistical differences were observed for the 223Q/R and À2548 G/A.
| Association between Leptin polymorphisms and obesity in all studied population
According dominant model and after adjustment to confounding parameters (age, gender, smoking status, HTA, diabetes, dyslipidaemia and cardiovascular disease), the OR of obesity associated with mutated genotypes for LEP 3 0 UTR A/C and LEPR109 K/R compared with normal genotype was as follows: OR = 2.63; 95% CI: [1.13-6.11]; P = .025), OR = 0.399; 95% CI: [0.179-0.892]; P = .025 (Table 3) respectively. Our results showed that concerning LEP À2548 G/A polymorphism, the OR of obesity associated with À2548 AA/GG was 1.87[1.106-2.78] P = .028, and concerning LEPR 223Q/R polymorphism, the OR of obesity associated with 223Q/R was 1.41[1.035-1.85] P = .045 (Table 4) .
| Correlation between serum Leptin levels and biological and anthropometric parameters
Results given in Table 5 showed that the serum Leptin concentration was significantly correlated with waist circumference (WC) R = 0.471 (P < .001), HDL-C 3.5 | ROC curve, PPV, NPV, sensibility and specificity of Leptin level in obesity Figure 1 shows the ROC curve plotted from the sensitivity and specificity values found for each Leptin level measured in the study sample, with obesity as the outcome. The best cut-off was Leptin value of 9.1 ng/mL (87.1% sensibility; 85% specificity) corresponded to the shoulder of the curve with positive predictive value (PPV) = 95.3% and negative predictive value (NPV) = 65.3%. The area under the curve represents the overall accuracy of the test (0.897).
| Haplotype frequency distribution and
Leptin level association SNP Analyzer showed 17 haplotypes (H), two of them seem to be significantly associated with obesity. Haplotypes follow this order: LEP À2548 G/A, LEPR 223Q/R, 3 0 UTR A/C; LEPR 109 K/R ( Table 6 ).
The more protective haplotype seems to be H9 «GAAG»; OR = 0.108 [0.021-0.567] (P = .005), and the highest risk seems to be associated to H3 «AGCA»; OR = 1.818 [0.928-3.558] (P = .002) ( Table 7) .
Comparison of Leptin level between these two haplotypes showed that the potential protective haplotype carriers (H9) had lower Leptin level 9. 
| DISCUSSION
Obesity is a multifactor disease, and many factors might be implicated-genetic, metabolic and environmental. It is clear that obesity is characterized by high levels of Leptin. 22 Leptin is an adipocyte-derived hormone, acting as a satiety signal by downregulating orexigenic peptides which stimulate intake food and upregulating anorexigenic peptides. Many mechanisms may contribute to change in Leptin level. 23 In humans LEP circulating levels correlate with obesity 9 and high Leptin levels are strongly associated with higher fat mass growth 24 and with weight reduction difficulties. 25 Its action occurs by means of the Leptin receptor, encoded by the LEPR gene. The complex Leptin-Leptin receptor is one of the regulatory pathways controlling obesity development. 26 Plasma Leptin levels are markedly increased in obese individuals, 27 and along the same lines, we examined Leptin levels in obese and non-obese subjects and its association with the LEP and LEPR polymorphism in Tunisian volunteers. Leptin concentrations in our obese group (41.6[0.05-148.8] ng/mL) were similar to those reported by Oksanen 19 .0 AE 13.3 ng/mL in control groups and 21.5 AE 21.5 ng/mL in obese subjects, respectively. In South Korea, Leptin levels in women were 7.79 AE 3.83 ng/mL in control and 12.59 AE 8.59 ng/mL in obese groups. 22, 28, 30 Leptin is considered a key element that decreases the food intake by stimulating the appearance of melanocortin, leading to an increase in the hypothalamic hormone a melanocyte-stimulating hormone (a-MSH). The a-MSH, while binding to its hypothalamic receptor MC4, decreases the food intake. Subsequently, the Leptin inhibits the activity of the orexigenic neurons type hypothalamic neuropeptide Y/agouti-related protein. The low level of Leptin causes some damage to this mechanism, leading to an increase in the food intake, thus obesity. 31 Also, we report that serum Leptin level was significantly associated with WC (P < .001) but not with BMI (P = .866). So it seems that in our population (rather than for general obesity) LEP is a better marker for visceral fat mass values.
In fact, Montazerifar et al 32 indicated that Leptin levels were significantly higher in abdominal obese patients than those in patients without abdominal obesity or in the control group. This result was partly consistent with earlier reports. 22, 33, 34 Others studies have shown that visceral adiposity is more associated with obesity 35, 36 and explained that additional factors derived from visceral adipose tissue such as inflammatory mediators may contribute to the effect of body fat distribution on obesity and other cardiovascular diseases.
In our study, we found significant correlation between Leptin serum levels and HOMA-IR R = 0.367 (P < .001). Along the same lines Wauters et al 37 and Motawi et al 38 reported that Leptin concentration in obese and diabetic subjects was significantly elevated compared to non-diabetic controls. Karacabey K argued that obesity leads to insulin resistance, 39 and insulin stimulates Leptin expression; in fact, an increase in serum Leptin levels in the obesity and type 2 diabetes was also reported. 40 Leptin secretion may interfere with glucose metabolism and insulin sensibility, and produce imbalance in glycaemia. We found that the Leptin levels are significantly correlated with HDL-C, R = 0.212 (P = .004), and the same results were previously reported by Ogawa et al. 41 This correlation with HDL-C may be explained by a decrease in TG; in liver, LEP decreases the glycogenolysis and increases the b-oxidation of fatty acids. 42, 43 In our population, we aimed not only to study the relationship between Leptin level and obesity but also to exanimate this relation with some polymorphisms in LEP and LEPR gene.
We found a significant association between À2548 G/A and 223 Q/R polymorphisms and obesity but not with Leptin concentration.
Data in the literature concerning the association between the LEP À2548 G/A polymorphism and obesity are controversial. A significant association between this polymorphism and obesity has been reported in different populations. 5, [44] [45] [46] But, negative results have also been found for African and Romanian populations.
19,47
Also, LEP variant of À2548 G/A and Leptin levels have been controversial; in healthy Greek individuals, the LEP À2548 G allele was found to be associated with increased serum Leptin levels through an interaction between fat mass and gender. 48 Conversely, in Turkish population Sahin et al 45 demonstrated that LEP À2548 AA or AG carriers have a significantly higher Leptin concentration comparing to À2548 GG genotype, 45 and these results were also found in French population. 44 These different results may be explained by many interactions of LEP À2548 G/A polymorphism with other gene polymorphisms in LEPR, adiponectin or others, by sample size or by ethnic differences. The À2548 G/A polymorphism is located at the region of 5 0 promoter of LEP gene and suggested that this region may contain transcription inhibitory elements in adipocytes. 49 In fact, Gong et al 49 described two repetitive sequences (MER11 and Alu) located on the promoter of the LEP (À2514 to 1545) susceptible to regulate the gene expression. The later identification of the transcription factor SP1 at the level of the repetitive sequence suggested that the expression of the LEP is the result of the insertion of this element at the level of the sequence MER11. 50 The position of the polymorphism À2548 G/A near a site known for connection of the SP1 (2539) may explain the possible implication in the regulation of the transcription of the LEP via an imbalance of connection with another functional polymorphism in the sequence MER11 still not identified. 50 Links between the LEPR variant of Gln223Arg (223Q/ R) and obesity have been controversial. However, significant association has been reported in different Caucasian populations. [51] [52] [53] In a population from Greece, the LEPR Q223R polymorphism was not only associated with obesity but also predicted a small variation in body composition. 54 In our study, we did not find any significant association between the 223 Q/R polymorphism and Leptin concentration; this is in the same line with Okada et al 55 who studied 136 obese children. Conversely, Riestra et al 56 showed that the Gln223Arg (223Q/R) polymorphism is associated with higher serum Leptin levels and BMI only in girls. A Mexican study conducted with 55 obese and 48 non-obese showed that the Gln223Arg (223Q/R) polymorphism was more prevalent among individuals with higher levels of insulin, body fat percentage and serum Leptin levels. Guizar-Mendoza et al 57 reported higher heart sympathetic activity and Leptin levels in the Gln (glutamine amino acids) carriers. LEPR Gln223Arg (223Q/R) polymorphism was associated with lower Leptin levels in postmenopausal Caucasian women. 58 Recently, Marginean et al 59 showed that the Leptin values associated with the LEPR 223 QQ genotype were higher in obese children vs controls. In our study, LEPR Arg109Lys (109 K/R) seems to show a significant association with serum Leptin levels (P < .001) and with obesity (P = .025).
Wauters et al 60 The Gln223Arg (223Q/R) polymorphisms are located in the cytokine receptor homologous 1 (CRH1) domain in LEPR. The function of this domain has still not been clarified and need to be studied more carefully. 66 The CRH domain contains a conserved WSXWS motif that is believed to be essential for proper folding of the domain. 67 Because of the location of these both polymorphisms, it is possible that it could also affect the function of LEPR. In a previous study, a deletion of CHR1 resulted in a lower LEP response, and it seems that CRH1 contributes to optimal LEPR activation. 68 To our knowledge, this is the first study to analyse the association between the effect of variants in the 3 0 flanking region of the LEP (3 0 UTR A/C) (rs11761556 A/C), obesity Recently, a novel class of functional variants termed miRSNPs were reported and defined as a variant at or near a lRNA binding site that can affect gene expression. 72 Furthermore, the 3 0 UTR of eukaryotic mRNAs play crucial roles in the posttranscriptional regulation of gene expression through the modulation of nucleocytoplasmic mRNA transport, translation efficiency, subcellular localization and message stability. 73 This heterogeneity in results may be explained by different genetic backgrounds or environmental conditions of the studied population than by the SNP itself. Also, in a polygenic disease such as obesity, with a strong environmental influence, genotype is only one factor in the causal pathway to the disease, and gene-gene and gene-environment interactions can influence the final association between genotype and disease.
In our study population, comparison of the haplotype frequencies between obese and non-obese groups showed significant difference for two haplotypes H9 «GAAG» which seems to be protective and it occurred more frequently in the non-obese than in obese group (P = .005), but H3 «AGCA» seems to be the most haplotype associated with obesity risk with OR = 1.818[0.928-3.558] (P = .002).
Concerning 
| CONCLUSION
In conclusion, this study showed that LEP 11761556 A/C and LEPR rs1137100 A/G polymorphisms seem to be associated with Leptin concentration and obesity in our
